Extensive studies have established the diagnostic utility of GPC3 in HCC, demonstrating an overall diagnostic sensitivity of 75–85% for HCC, which could be maintained as high as 89% in poorly differentiated HCC, and GPC3 outperforms HepPar1 (sensitivity 64%) [31,32]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.